Consolidated Statements of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012		Sep. 30, 2013		Sep. 30, 2012
Net sales	$ 648,638		$ 661,226		$ 1,924,460		$ 2,057,824
Cost of goods sold	436,989		443,476		1,316,582		1,339,806
Gross profit	211,649		217,750		607,878		718,018
Selling, general and administrative expenses	62,543		53,404		190,193		189,143
Research and development expenses	19,441		19,831		60,959		59,791
Restructuring and other charges, net (Note 13)	0	[1]	0	[1]	0	[1]	94,703	[1]
Operating profit	129,665		144,515		356,726		374,381
Interest and financing expenses	(9,496)		(7,914)		(22,335)		(25,134)
Other (expenses) income, net	(389)		2,370		(6,295)		1,564
Income before income taxes and equity in net income of unconsolidated investments	119,780		138,971		328,096		350,811
Income tax expense	27,274		32,472		74,916		93,382
Income before equity in net income of unconsolidated investments	92,506		106,499		253,180		257,429
Equity in net income of unconsolidated investments (net of tax)	5,338		7,935		25,308		29,233
Net income	97,844		114,434		278,488		286,662
Net income attributable to noncontrolling interests	(7,332)		(4,975)		(21,250)		(12,852)
Net income attributable to Albemarle Corporation	$ 90,512		$ 109,459		$ 257,238		$ 273,810
Basic earnings per share (in dollars per share)	$ 1.11		$ 1.23		$ 3.04		$ 3.07
Diluted earnings per share (in dollars per share)	$ 1.11		$ 1.22		$ 3.02		$ 3.04
Weighted-average common shares outstanding - basic (in shares)	81,385		89,327		84,711		89,246
Weighted-average common shares outstanding - diluted (in shares)	81,852		89,879		85,192		89,959
Cash dividends declared per share of common stock (in dollars per share)	$ 0.24		$ 0.20		$ 0.72		$ 0.60

[1] See Note 13, “Restructuring and Other.”